Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-16-163886
Filing Date
2016-12-27
Accepted
2016-12-27 16:11:48
Documents
2
Period of Report
2016-12-22

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 4110
2 EX-24.1 ex-24d1.htm EX-24.1 10076
  Complete submission text file 0001104659-16-163886.txt   15868
Mailing Address 887 GREAT NORTHERN WAY SUITE 250 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 250 VANCOUVER A1 V5T 4T5 6047077000
NOVELION THERAPEUTICS INC. (Issuer) CIK: 0000827809 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address DORSET MANAGEMENT CORP 485 UNDERHILL BLVD SUITE 205 SYOSSET NY 11791
Business Address
Sabba Stephen L (Reporting) CIK: 0001442372 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-17082 | Film No.: 162070786